Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sugammadex: An Update.

Literature DB >> 29967832

Sugammadex: An Update.

Tiberiu Ezri^1,2, Mona Boaz³, Alexander Sherman¹, Marwan Armaly⁴, Yitzhak Berlovitz⁵.

Abstract

The purpose of this update is to provide recent knowledge and debates regarding the use of sugammadex in the fields of anesthesia and critical care. The review is not intended to provide a comprehensive description of sugammadex and its clinical use.

Keywords: aminosteroidal group; muscle relaxants; neostigmine; reversal; sugammadex

Year: 2016 PMID： 29967832 PMCID： PMC5939138 DOI： 10.1515/jccm-2016-0005

Source DB: PubMed Journal: J Crit Care Med (Targu Mures) ISSN： 2393-1817

Keyword Cloud
References

28 in total

1. Use of sugammadex in a 'can't intubate, can't ventilate' situation.

Authors: R Curtis; S Lomax; B Patel
Journal: Br J Anaesth Date: 2012-01-26 Impact factor: 9.166

2. The duration of residual neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring.

Authors: Hanna L Illman; Päivi Laurila; Heikki Antila; Olli A Meretoja; Seppo Alahuhta; Klaus T Olkkola
Journal: Anesth Analg Date: 2010-10-26 Impact factor: 5.108

3. Sugammadex to rescue a 'can't ventilate' scenario in an anticipated difficult intubation: is it the answer?

Authors: C Mendonca
Journal: Anaesthesia Date: 2013-08 Impact factor: 6.955

4. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.

Authors: Louis-Philippe Fortier; Dolores McKeen; Kim Turner; Étienne de Médicis; Brian Warriner; Philip M Jones; Alan Chaput; Jean-François Pouliot; André Galarneau
Journal: Anesth Analg Date: 2015-08 Impact factor: 5.108

10. Neuromuscular monitoring, muscle relaxant use, and reversal at a tertiary teaching hospital 2.5 years after introduction of sugammadex: changes in opinions and clinical practice.

Authors: Thomas Ledowski; Jing Shen Ong; Tom Flett
Journal: Anesthesiol Res Pract Date: 2015-01-22

Sugammadex: An Update.

1. Use of sugammadex in a 'can't intubate, can't ventilate' situation.

2. The duration of residual neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring.

3. Sugammadex to rescue a 'can't ventilate' scenario in an anticipated difficult intubation: is it the answer?

4. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.

5. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.

Review 6. Hypersensitivity associated with sugammadex administration: a systematic review.

7. Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment.

8. Rocuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia.

9. Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients.

10. Neuromuscular monitoring, muscle relaxant use, and reversal at a tertiary teaching hospital 2.5 years after introduction of sugammadex: changes in opinions and clinical practice.